Bharat Biotech announces the quick ramp-up of additional manufacturing capacities for COVAXIN at Chiron Behring Vaccines, Ankleshwar, Gujarat, a wholly-owned subsidiary of Bharat Biotech.


The Company had already deployed multiple Production lines at its Hyderabad & Bengaluru campuses, adding Chiron Behring to this line up of high containment BSL rated GMP facilities that are required to manufacture COVAXIN
This effectively takes the volumes upto around 1 Billion doses per annum, with its own established campuses specialised for manufacturing inactivated viral vaccines under the highest levels of biosafety: Bharat Biotech